Product Overview
UA PAN-D Capsules is a combination therapy containing Pantoprazole Gastro-Resistant 40 mg and Domperidone Prolonged Release 30 mg. It is formulated to provide effective relief from acid-related gastrointestinal disorders by reducing gastric acid secretion and improving gastrointestinal motility.
The gastro-resistant formulation of Pantoprazole ensures targeted release in the intestine for optimal absorption, while Domperidone prolonged-release technology offers sustained symptom control throughout the day.
Composition
Each capsule contains:
- Pantoprazole Gastro-Resistant IP – 40 mg
- Domperidone Prolonged Release IP – 30 mg
- Excipients – q.s.
Mechanism of Action
Pantoprazole
Pantoprazole is a Proton Pump Inhibitor (PPI) that selectively inhibits the H⁺/K⁺ ATPase enzyme system (proton pump) in gastric parietal cells.
Action:
- Suppresses gastric acid secretion.
- Provides long-lasting acid control.
- Promotes healing of acid-related mucosal damage.
- Reduces heartburn and acid reflux symptoms.
Domperidone
Domperidone is a Dopamine D₂ Receptor Antagonist with prokinetic properties.
Action:
- Enhances gastric emptying.
- Improves gastrointestinal motility.
- Reduces nausea and vomiting.
- Minimizes reflux of stomach contents into the esophagus.
Combined Therapeutic Effect
The combination works synergistically by:
- Reducing excessive acid production.
- Accelerating gastric emptying.
- Preventing acid reflux episodes.
- Providing comprehensive symptom relief in GERD and dyspepsia.
Indications
UA PAN-D Capsules may be prescribed for:
- Gastroesophageal Reflux Disease (GERD)
- Acid Reflux
- Heartburn
- Gastritis
- Functional Dyspepsia
- Hyperacidity
- Peptic Ulcer Disease
- Nausea associated with gastric disorders
Indigestion and Bloating
Reviews
There are no reviews yet.